Stock listing
Chiome Bioscience Inc.
Selected listing: 4583 · TSE · JPY · JP
Chiome Bioscience Inc. (Tokyo:4583), Health Technology. Latest release Aug 13, 2026: Non-Consolidated Financial Results (Japanese GAAP) for the Six Months…
- Ticker
- Tokyo:4583
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- Tokyo
- Currency
- JPY
About Chiome Bioscience Inc.
Chiome Bioscience Inc. is a public company listed under the ticker 4583 in the Japanese market. Chiome focuses on developing innovative biopharmaceuticals and is committed to advancing healthcare solutions.
Latest news from Chiome Bioscience Inc.
Non-Consolidated Financial Results (Japanese GAAP) for the Six Months Ended June 30,2026
August 13, 2026
Chiome Bioscience : Announcement of target-specific research and option agreement with Heidelberg Pharma
July 13, 2022
Chiome Bioscience : Service agreement with option contract with Rohto Pharmaceutical Co., Ltd.
July 11, 2022
Chiome Bioscience : First patient in of cancer therapeutic antibody CBA-1535 in a Phase 1 clinical trial
July 4, 2022
Chiome Bioscience : Conclusion of contract with additional institutes and first dosing of CBA-1205 in the second part of Phase 1 study
June 13, 2022
Research Chiome Bioscience Inc.
Chiome Bioscience Inc. company profile
View the public company page for Chiome Bioscience Inc. on 6ix.
Chiome Bioscience Inc. news
Read company news and market updates connected to Chiome Bioscience Inc..
Chiome Bioscience Inc. investor events
Find investor webinars, events, and replay context for Chiome Bioscience Inc..